Viewing Study NCT00396968


Ignite Creation Date: 2025-12-24 @ 5:50 PM
Ignite Modification Date: 2025-12-28 @ 5:31 PM
Study NCT ID: NCT00396968
Status: WITHDRAWN
Last Update Posted: 2014-02-11
First Post: 2006-11-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: AMD3100 With Busulfan, Fludarabine and Thymoglobulin for Allogeneic Stem Cell Transplant for AML and MDS
Sponsor: Genzyme, a Sanofi Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module